Genentech, Inc. - Company & Market Research Reports

Home /
Companies /
Genentech, Inc.

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 113
Immune Disorders Drugs 49
Biopharmaceuticals 37
Genomics 33
Central Nervous System Drugs 32
Drug Discovery 30
Optical Disorders Drugs 28
Optical 27
Pharmaceuticals 26
Respiratory Drugs 24
Biotechnology 23
Hematological Drugs 23
Endocrine and Metabolic Disorders Drugs 23
Cardiovascular Drugs 19
Clinical Trials 19
Breast Cancer Drugs 18
Lung Cancer Drugs 17
Infusions and Injectables 17
Musculoskeletal Disorders Drugs 17
Women's Health 16
Oncology 15
Allergy and Immunology 14
Infectious Diseases Drugs 14
Biosimilars and Biosuperiors 14
Liver and Kidney Disorders Drugs 13
Pulmonary Medicine 12
Lymphoma Drugs 12
Colon Cancer Drugs 12
Leukemia Drugs 11
Enzymes 11
Skin Cancer Drugs 11
Pharmaceutical Manufacturing 11
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Brain Cancer Drugs 10
Diagnostics 10
Kidney Cancer Drugs 10
Drug Delivery 9
Needles and Syringes 8
Bladder Cancer Drugs 7
Hematology 7
Pancreatic Cancer Drugs 7
Dermatological Drugs 7
Allergy Drugs 7
Liver Cancer Drugs 6
Sexual and Reproductive Health Drugs 6
Therapeutic Area 5
Drugs by Therapeutic Area 5
Gastrointestinal Drugs 5
Urological Disorders Drugs 5
Immunosuppressive Drugs 5
Pharmaceutical Intermediates 4
Neurology 4
Healthcare Services 4
Hospital Information Systems 4
Dermatology 4
Vaccines 4
Diabetes Drugs 3
Prostate Cancer Drugs 3
In Vitro Diagnostics 3
Transdermal and Transmucosal Drug Delivery 3
Medical Devices 3
Thyroid Cancer Drugs 3
Cardiology 3
Alzheimer's Disease Drugs 3
Company Reports 2
Animal Pharmaceuticals 2
Urology and Nephrology 2
Hepatology 2
Proteomics 2
Infectious Disease Testing 2
Laboratory Testing 2
Biomaterials 2
Cancer Vaccines 2
Uterine Cancer Drugs 2
Nanomedicine 2
Laboratory Equipment 2
Pediatrics 2
HIV/AIDS Drugs 2
Psoriasis Drugs 2
Patient Monitoring Equipment 1
Generic Drugs 1
Pharmacoeconomics 1
Medical Imaging 1
Drug Abuse Screening 1
Analgesics 1
Cough and Cold Drugs 1
Managed Care 1
Radiography 1
Stem Cells 1
Biomarkers 1
Over the Counter (OTC) Drugs 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Antibiotics 1
Gastroenterology 1
Endocrinology 1
Maternal and Neonatal Care 1
Asthma Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

680 Results (Page 22 of 34)
- Relevance
  Sort by

Breast Cancer Therapeutics Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy, Breast Cancer Type, Distribution Channel, and Geography

 Report
October 2023
204 Pages
Global

From

€4095EUR$4,450USD£3,420GBP

Growth Hormone Deficiency - Global Strategic Business Report

 Report
November 2026
475 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Antiglaucoma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4131EUR$4,490USD£3,451GBP

Implantable Drug Delivery Devices Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4131EUR$4,490USD£3,451GBP

Glomerulonephritis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1840EUR$2,000USD£1,537GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Microbiome Therapeutics: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

 Report
October 2022
220 Pages
Global

From

€1747EUR$1,899USD£1,459GBP

Biobetters Market by Drug Class, by Disease Indication, by Route of Administration, by Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3819EUR$4,150USD£3,189GBP

Cerebral Infarction Treatment - Global Strategic Business Report

 Report
November 2026
372 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

GLP-1 Receptor Agonist - Global Strategic Business Report

 Report
November 2026
483 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Plexiform Neurofibromas Treatment - Global Strategic Business Report

 Report
November 2026
372 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Neurodegenerative Diseases Therapeutics - Global Strategic Business Report

 Report
November 2026
387 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Oncology Biosimilars Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
120 Pages
Global

From

€4141EUR$4,500USD£3,458GBP

Lung Cancer Diagnosis and Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
118 Pages
Global

From

€3500EUR$4,075USD£3,025GBP

Anti-Cancer MAbS Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4131EUR$4,490USD£3,451GBP

Mantle Cell Lymphoma Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
105 Pages
Global

From

€3500EUR$4,075USD£3,025GBP

MRNA Vaccines and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
January 2026
159 Pages
Global

From

€4371EUR$4,750USD£3,650GBP

Retinal Disorder Treatment - Global Strategic Business Report

 Report
November 2026
375 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Retinal Vein Occlusion Treatment - Global Strategic Business Report

 Report
November 2026
373 Pages
Global

From

€5383EUR$5,850USD£4,496GBP

Severe Acute Respiratory-Syndrome Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4131EUR$4,490USD£3,451GBP

Geographic Atrophy (GA)- Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1840EUR$2,000USD£1,537GBP

680 Results (Page 22 of 34)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.